Stefania Terracciano
Affiliations: | University of Salerno |
Google:
"Stefania Terracciano"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pierri M, Bove G, Gazzillo E, et al. (2025) Unveiling New Triazoloquinoxaline-based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9. Chemistry (Weinheim An Der Bergstrasse, Germany). e202404218 |
| Nardone V, Ruggiero D, Chini MG, et al. (2025) From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies. Cancers. 17 |
| Ruggiero D, Ingenito E, Boccia E, et al. (2025) Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways. European Journal of Medicinal Chemistry. 287: 117358 |
| Ruggiero D, Ingenito E, Boccia E, et al. (2024) Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold. Molecules (Basel, Switzerland). 29 |
| Di Micco S, Ruggiero D, Terracciano S, et al. (2024) Identification of honokiol-based scaffold to design tankyrase 1/2 inhibitors by in silico and in vitro studies. Chemistry & Biodiversity. e202401854 |
| Colarusso E, Gazzillo E, Boccia E, et al. (2024) Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign. Molecules (Basel, Switzerland). 29 |
| Colarusso E, Gazzillo E, Pierri M, et al. (2024) In Silico Design, Chemical Synthesis, Biophysical and In Vitro Evaluation for the Identification of 1-ethyl-1H-pyrazolo[3,4-b]pyridine-based BRD9 Binders. Chempluschem. e202400339 |
| Capuano A, D'Urso G, Aliberti M, et al. (2024) Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A. Marine Drugs. 22 |
| De Vita S, Meninno S, Capasso L, et al. (2023) 2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines. Bioorganic & Medicinal Chemistry. 93: 117444 |
| Gazzillo E, Pierri M, Colarusso E, et al. (2023) Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9. Bioorganic Chemistry. 139: 106677 |